CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemothe ...
Phase 2
Kansas City, Kansas, United States and 8 other locations
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...
Phase 3
Kansas City, Missouri, United States and 70 other locations
Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNB ...
Phase 1, Phase 2
Kansas City, Kansas, United States and 6 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Kansas City, Missouri, United States and 49 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Kansas City, Kansas, United States and 506 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Kansas City, Kansas, United States and 508 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Kansas City, Missouri, United States and 357 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
Westwood, Kansas, United States and 21 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Westwood, Kansas, United States and 260 other locations
This is a Phase II, two part trial (A and B), open label study of Atezolizumab and tiragolumab, or atezolizumab combined with SOC chemotherapy in pat...
Phase 2
Kansas City, Missouri, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal